✦ LIBER ✦

Use of Inno-Lipa HBV-DR to assess the sensitivity of lamivudine-resistant HBV mutants to adefovir

✍ Scribed by Vincent Thibault; Yves Benhamou; Olivier Lada; Fabienne Mousnier; Marie Bochet; Shelly Xiong; Carol Brosgart; Erwin Sablon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early detection of lamivudine-resistant

✍ A.M. Roque-Afonso; M.P. Ferey; L. Fki; V. Mackiewicz; E. Dussaix 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Early detection and monitoring of varian

✍ Maria Buti; Auristela Valdes; Montserrat Cotrina; Rosendo Jardi; Francisco Rodri 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Lamivudine treatment of chronic hepatiti

✍ R. Romeo; P. Lampertico; G. Zadra; M. Colombo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 132 KB

The INNO-LiPA HBV-DR assay is superior t

✍ H.L. Tillmann; H. Wedemeyer; C.T. Bock; A. Finger; I. Glomb; P. Magerstest; C. T 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 320 KB

P.101 Unusual selection of rta181V HBV m

✍ R. Gerolami; M. Bourliere; P. Colson; P. Halfon; P. Borentain; D. Botta; V. Calv 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

[498] HIGH BASELINE HBV-DNA IS LINKED TO

✍ S. Kaymakoglu; R. Idilman; E. Ahishali; F.O. Onder; M. Bektas; S. Badur; M. Bozd 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 267 KB